Ophthalmology · Roseville, CA
NPI
1770744351
Since 2008
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1001 Riverside Ave
Roseville, CA, 95678
Phone (916) 784-4185
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$323K
2,356 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Michele S Todman prescribed most often to Medicare patients was Cyclosporine, with 356 prescriptions and refills. In total Michele S Todman wrote 2,356 Medicare prescriptions that cost $323K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-11.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Cyclosporine Generic | 356 | 881 | 156 | $79K |
| Latanoprost Generic | 354 | 1,125 | 160 | $5,495 |
| Prednisolone Acetate Generic | 352 | 387 | 220 | $18K |
| Brimonidine Tartrate Generic | 241 | 760 | 96 | $7,344 |
| Polymyxin B Sul-Trimethoprim Polymyxin B Sulf/Trimethoprim | 239 | 242 | 175 | $2,987 |
| Rhopressa Netarsudil Mesylate | 163 | 213 | 40 | $75K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 139 | 458 | 53 | $3,703 |
| Tafluprost Tafluprost/Pf | 57 | 78 | 12 | $11K |
| Dorzolamide-Timolol Dorzolamide/Timolol/Pf | 50 | 78 | 12 | $7,179 |
| Timolol Maleate Generic | 41 | 128 | 19 | $769 |
| Xiidra Lifitegrast | 36 | 42 | Under 11 | $31K |
| Dorzolamide Hcl Generic | 34 | 107 | 17 | $950 |
| Nevanac Nepafenac | 31 | 31 | Under 11 | $11K |
| Valacyclovir Valacyclovir Hcl | 29 | 82 | 12 | $1,828 |
| Bimatoprost Generic | 27 | 88 | 14 | $3,076 |
Brand drugs: 1,079 claims; generic drugs: 1,277 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Michele S Todman were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.